Zoetis (ZTS) return on equity (ROE)

Return on equity · fiscal 2025
80.2%

Zoetis (ZTS) earned a return on equity of 80.2% in fiscal 2025 (the year ended December 31, 2025). That is 28.1 percentage points higher than the 52.1% of fiscal 2024. Figures as of 17 Nov 2026, 20:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
80.2%
Change on fiscal 2024
+28.1 pts
Highest on record
80.2%fiscal 2025
Lowest on record
6.6%fiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Zoetis return on equity (ROE), in more detail

Across the 15 fiscal years on record (2011–2025), the highest was 80.2% in fiscal 2025 and the lowest 6.6% in fiscal 2011. The fiscal 2025 figure is higher than in every one of the 14 earlier fiscal years on record, whose median is 47.4%.

History · 15 fiscal years

Return on equity by fiscal year

Zoetis return on equity (ROE), year by year

Zoetis (ZTS) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202580.2% 28.1 pts up
202452.1% 5.2 pts up
202346.9% 1.1 pts down
202248.0% 3.2 pts up
202144.8% 1.4 pts up
202043.5% 11.9 pts down
201955.4% 10.0 pts down
201865.4% 16.5 pts up
201748.8% 6.4 pts down
201655.2% 23.5 pts up
201531.7% 12.7 pts down
201444.5% 9.1 pts down
201353.6% 42.8 pts up
201210.8% 4.3 pts up
20116.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Zoetis and comparable companies
CompanyReturn on equityFiscal year
Mettler-Toledo International MTD3519.1%2022
Centene CNC-33.4%2025
Genmab GMAB16.5%2025
Illumina ILMN31.2%2025
ResMed RMD23.1%2026
Zoetis ZTS80.2%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ZTS

Zoetis, figure by figure

Zoetis (ZTS) overview: price, valuation and scorecardAll health care companies by market value

Zoetis return on equity (ROE): questions and answers

What is Zoetis's return on equity?

Zoetis (ZTS) earned a return on equity of 80.2% in fiscal 2025 (the year ended December 31, 2025). That is 28.1 percentage points higher than the 52.1% of fiscal 2024.

Is Zoetis's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 14 earlier fiscal years on record, whose median is 47.4%.

What are the highest and lowest return on equity figures on record for Zoetis?

Across the 15 fiscal years on record (2011–2025), the highest was 80.2% in fiscal 2025 and the lowest 6.6% in fiscal 2011.

How is Zoetis's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Zoetis (ZTS) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/ZTS/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.